Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MASIMO CORPORATION

(MASI)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Insider Trends: Insider Purchase Prolongs Masimo Positive Trend

05/04/2021 | 04:19pm EDT


© MT Newswires 2021
All news about MASIMO CORPORATION
06/14MASIMO  : New Study Investigates the Impact of ORi™-Guided Oxygen Titratio..
PU
06/14MASIMO  : New Study Investigates the Impact of ORi-Guided Oxygen Titration on Hy..
BU
06/01INSIDER TRENDS : Insider at Masimo Reports Option Conversion in Mist of 90-Day B..
MT
06/01INSIDER TRENDS : Insider at Masimo Converts Options in Mist of 90-Day Buying Tre..
MT
06/01INSIDER TRENDS : Masimo Insider Exercises Options Extending 90-Day Buying Trend
MT
06/01INSIDER TRENDS : Masimo Insider Reports Option Conversion Extending 90-Day Buyin..
MT
06/01MASIMO CORP  : Change in Directors or Principal Officers, Submission of Matters ..
AQ
05/20MASIMO V. APPLE : Remote Depositions Ordered If Deponent Has Not Attended Any In..
AQ
05/19MASIMO  : to Present in UBS Global Healthcare Virtual Conference
BU
05/17MASIMO  : New Study Assesses the Effects of Masimo Patient SafetyNet™ on N..
BU
More news
Financials (USD)
Sales 2021 1 207 M - -
Net income 2021 224 M - -
Net cash 2021 776 M - -
P/E ratio 2021 58,5x
Yield 2021 -
Capitalization 12 348 M 12 348 M -
EV / Sales 2021 9,59x
EV / Sales 2022 8,48x
Nbr of Employees 2 000
Free-Float 70,7%
Chart MASIMO CORPORATION
Duration : Period :
Masimo Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MASIMO CORPORATION
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 8
Average target price 280,67 $
Last Close Price 224,51 $
Spread / Highest target 38,1%
Spread / Average Target 25,0%
Spread / Lowest Target -13,1%
EPS Revisions
Managers and Directors
NameTitle
Joe E. Kiani Chairman & Chief Executive Officer
Micah Young Chief Financial Officer & Executive Vice President
Yongsam Lee Chief Information Officer & Executive VP
Anand Sampath Executive VP-Operations & Clinical Research
Jon Curtis Coleman President-Worldwide Sales & Medical Affairs
Sector and Competitors
1st jan.Capitalization (M$)
MASIMO CORPORATION-16.35%12 348
NOVOCURE LIMITED27.49%22 813
GETINGE AB61.17%10 087
PENUMBRA, INC.57.35%10 046
SHOCKWAVE MEDICAL, INC.86.74%6 776
ASAHI INTECC CO., LTD.-30.73%6 448